[Results of multicenter study of efficacy and safety of divaza in the treatment of the asthenic and mild to moderate cognitive disorders in elderly and senile subjects]. / Rezul'taty mnogotsentrovogo issledovaniia éffektivnosti i bezopasnosti primeneniia preparata divaza pri astenicheskikh i legkikh ili umerennykh kognitivnykh rasstroistvakh v pozhilom i starcheskom vozraste.

AIM: To study the efficacy and safety of divasa in elderly and senile subjects with asthenic and mild to moderate cognitive disorders. MATERIAL AND METHODS: The study included 126 patients with clinically significant asthenia and mild to moderate cognitive disorders. Asthenia was assessed with MFI-20, cognitive disorders with MMSE, clock drawing test and verbal association test. All patients were treated with divasa in dose 2 tablets 3 times a day. RESULTS AND CONCLUSION: The efficacy and safety of divasa in asthenic and mild to moderate cognitive disorders in elderly and senile subjects were shown. There is a need for a multicenter placebo-controlled trial on the efficacy of divasa to treat cognitive and asthenic disorders in elderly patients.